Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency
- 1 February 1994
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 107 (2) , 543-553
- https://doi.org/10.1016/s0022-5223(94)70101-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- High-dose aprotinin in cardiac surgery: Three years' experience in 1,784 patientsJournal of Cardiothoracic and Vascular Anesthesia, 1992
- High-dose aprotinin therapy: A review of the first five years' experienceJournal of Cardiothoracic and Vascular Anesthesia, 1992
- Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- Sensitivity and specificity of assessing coronary bypass graft patency with ultrafast computed tomography: Results of a multicenter studyJournal of the American College of Cardiology, 1988
- Evaluation of coronary bypass graft patency by ultrafast computed tomographyJournal of Thoracic Imaging, 1988
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Fifteen hundred coronary reoperationsThe Journal of Thoracic and Cardiovascular Surgery, 1987
- Prospective evaluation of ultrafast cardiac computed tomography for determination of coronary bypass graft patency.Circulation, 1987